Concepedia

Beverly Knight

BK

7

Publications

282

Citations

7

H-Index

2011

Active since

Affiliations

Pfizer (United States)(Current)

University of North Carolina at Chapel Hill

Beverly Knight is an author at Pfizer (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyOncologyHematologyBiochemistryMetabolismPhysiologyToxicologyDrug Discovery

Publications per year

2011–2024

7

Publications

7

Vectorial Transport of Fexofenadine across Caco-2 Cells: Involvement of Apical Uptake and Basolateral Efflux Transporters

Xin Ming, Beverly Knight, Dhiren R. Thakker · Molecular Pharmaceutics · 2011 · 84 citations

Vectorial Transport System, Pharmacotherapy, Digestive Tract +16

Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton’s Tyrosine Kinase

Christopher R. Smith, Douglas R. Dougan, Mallareddy Komandla et al. · Journal of Medicinal Chemistry · 2015 · 73 citations · Full text

Drug Target, Bioorganic Chemistry, Tyrosine Kinase +18

A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers

Beverly Knight, Danielle Rassam, Shanmei Liao et al. · Cancer Chemotherapy and Pharmacology · 2016 · 50 citations · Full text

Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia

Jennifer Hibma, Beverly Knight · Clinical Pharmacokinetics · 2018 · 21 citations

Hematological Malignancy, Oncology, Pharmacokinetic Modeling +10

P-Glycoprotein Increases Portal Bioavailability of Loperamide in Mouse by Reducing First-Pass Intestinal Metabolism

Matthew B. Dufek, Beverly Knight, Arlene S. Bridges et al. · Drug Metabolism and Disposition · 2013 · 20 citations

Rows per page

1–5 of 7